CROI 2012: Global Pediatric Issues

"Global Pediatric AIDS Issues" Panel including: Polly Clayden, Director, i-Base, London, UK; and Rachael Cohen, Regional Executive Director, Drugs for Neglected Diseases Initiative in North America. Panel hosted by Fred Schaich, IFARA, Portland, OR.

The panel addresses the complex issues facing providers and caregivers for the 3.4 million children living with HIV/AIDS. It covers treatment access, HIV treatment formulations, importance for PCR method for early diagnosis in the developing world, moving from antiquated first line pediatric formulations, moving from breast feeding to formula, and TB and HIV contemporary treatment.

CROI 2012: Julie Overbaugh - Superinfection

Julie Overbaugh, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA

Dr. Overbaugh explains what superinfection is, as different from dual infection or evolving strains, and how this distinction may be important in the clinic. She also describes some of the novel research that was presented, and how some of the research informs policy not only in the clinic but in human behavior in prevention and especially in the zoonotic transmissions through bush meat in Africa.

CROI 2012: Eric Lefebvre - Cenicriviroc

Eric A. Lefebvre, MD, Chief Medical Officer, Tobira Therapeutics.

Eric describes the phase IIb trial of Cenicriviroc, which will decide the single daily dose to move forward with into the Phase III trial. He also discusses the anti-inflammatory benefit of Cenicriviroc through the CCR-2 blocking function of this compound.

CROI 2012: Alberto La Rosa

Alberto La Rosa, MD, Investigador, Impacta, Asociación Civil Impacta Salud y Educación, Lima, Peru.

Interview in Spanish by Rob Camp

CROI 2012: I Clinici Italiani Intervistati da Nadir: Stato Dell'arte Della Terapia e Prospettive Verso una Cura per L'HIV

Host: Filippo von Schosser, Roma, Italy.


Andrea Antinori, MD, National Institute for Infectious Diseases.

Lazzaro Spallanzani, Istituto di Ricovero e Cura a Carattere, Via Portuense, Roma, Italy.

Massimo Galli, MD, Institute of Infectious and Tropical Diseases, University of Milan, Milan, Italy.

Massimo Andreoni, MD, Division of Infectious Diseases, Ospedale degli Infermi, Biella, Italy.

CROI 2012: Co-Morbidities and Metabolic Complications in HIV

Hosted by Jeff Taylor, Treatment Advocate, Palm Springs, CA.

Panelists include:

Michael Dube, Professor of clinical Medicine at USC, Keck School of Medicine, Division of Infectious Disease, Los Angeles, CA.

Edgar Turner Overton, MD, Assistant Professor, Alabama Vaccine Research Clinic, University of Alabama at Birmingham School of Medicine, Department of Medicine, Division of Infectious Diseases, Birmingham, AL.

David Alain Wohl, MD, University of North Carolina, Institute for Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill, NC.

Ronald T. Mitsuyasu, MD, Director of the Center for Clinical AIDS Research and Education at UCLA (CARE), Professor of Medicine in Residence at the UCLA David Geffen School of Medicine, and an Associate Director of the UCLA AIDS Institute.

CROI 2012: Enid Vasquez

Enid Vasquez, TPAN, Chicago, IL, EEUU, Entrevista en castellano por Rob Camp.

Enid nos recuerda de la importancia de la prevención y como podemos tomar mas control sobre el asunto. 15 minutos.

CROI 2012: Carlos del Rio

Carlos del Rio, MD, Profesor, Robert W. Woodruff Health Sciences Center, Universidad de Emory, Atlanta, GA, USA.

Entrevista en castellano por Rob Camp. Carlos subraya la importancia del momento en que nos encontramos sobre la manera de parar la epidemia de una vez por todas. 15 minutos.

CROI 2012: Michael Emerman

Michael Emerman, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA.

Dr. Emerman presented at a CROI plenary, discussing why and how humans are susceptible to HIV, and therefore the genetic relationships to targets, and how to disrupt this process creating an antiviral effect. He also contributes his perspective on what he will take away from this year’s CROI.

CROI 2012: Antiretrovirals Panel

CROI 2012: Andrea Calgagno - Young Investigators

Andrea Calgagno, Department of Infectious Diseases, University of Torino, Torino, Italy.

Young Investigator Interview – by Fred Schaich, IFARA, Portland, OR. His research evaluates drug dose reduction to minimize toxicity and save costs so more can be treated with the same funds. He also provides some insight into the challenges he faces as a young investigator.

CROI 2012: "The Cure" Panel

CROI 2012: Joel Gallant

CROI 2012: French-language Panel

In French.

CROI 2012: Aging Panel

CROI 2012: Dorothy Mbori-Ngacha

CROI 2012: German-language Panel

Möglicher neuer Behandlungsansatz von der 19. Retrovirus Conference (CROI) in Seattle, USA (auf Deutsch).

Interviewer: Siegfried Schwarze, Projekt Information e.V., München, Deutschland.

Interview mit: Prof. Dr. med. Gerd Fätkenheuer, Köln, Deutschland.

CROI 2012: Kevin DeCock

CROI 2012: Julio Montaner

In Spanish.

CROI 2012: Women in Research Panel

CROI 2012: Spanish-language Panel

Actualización de Tratamientos 2012 (Treatment Update 2010) in Spanish, hosted by Rob Camp, Barcelona, Spain.

Panel includes: Pablo Tebas, MD, University of Pennsylvania, Philadelphia, PA, and Juliá Blanco, MD, IrsiCaixa Foundation, Badalona, Spain.

CROI 2012: Treatment Update Program

Treatment Update 2012, from the 19th CROI in Seattle, Washington.

Three panels cover Antretrovirals, Metabolics and Co-Morbidities, and HIV and Hepatitis Co-infection.
These panels will be available for separate viewing, soon.

CROI 2012: Advances in HIV Prevention Research

"Advances in HIV Prevention Research" Panel includes: Carl Dieffenbach, PhD, Director, Division of AIDS, National Institutes of Health National Institute of Allergy and Infectious Diseases, Bethesda, MD; Nelly Mugo, MD, MPH, Research Scientist at the University of Washington, University of Nairobi/Kenyatta National Hospital (KNH) and East African Director of the Partners in Prevention HSV/HIV Transmission Study; Julio Montaner, MD, Director of the British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada. Hosting this panel: Yasmin Halima, Executive Director, The Global Campaign for Microbicides at PATH.

This panel discusses progress in biomedical prevention technologies for women, and treatment as prevention.

CROI 2012: Prevention

CROI 2012: Dalton Wamalwa

CROI 2012: Salim S. Abdool Karim - CAPRISA Trial

Salim S. Abdool Karim, PhD, Director, CAPRISA Trial, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Congella, South Africa. He refreshes our memory of the recent success over the past 18 months of CAPRISA study on microbicide gel, and the somewhat unsuccessful trial using tablets, and another trial which provides more success where the compounds are actually taken by the trial participants.

Dr. Abdool Karim covers the behavioral aspects of the trial, mission focused research investment, community role model leadership, and future demonstration projects.

CROI 2012: Santiago Moreno

Santiago Moreno, MD, PhD, Hospital Ramón y Cajal, Madrid, Spain, Interview in Spanish by Rob Camp.

CROI 2012: Eric Goosby - PEPFAR

Ambassador Eric Goosby, MD, U.S. President’s Emergency Plan For AIDS Relief, Washington, DC.

Ambassador Goosby gives a brief history of President Bush’s PEPFAR program from an initial 14 countries to now 80 countries in the current presidential administration, including treatment, facilities/infrastructure, care and education. He covers the way in which the program moves from emergency to sustainability of core services through greater collaboration with countries' ministries of health, civil societies, public sector clinics/hospitals, faith-based organizations, other organizations and community. Lessons learned are also discussed as the U.S. will likely be able to utilize some of the models from Africa.

CROI 2012: HIV Medicine Association Panel

"HIVMA - HIV Medicine Association" Panel including Michael Horberg, MD, Chair Elect to HIVMA and Director HIV/AIDS, Kaiser Permanente, Rockville, MD; and Joel Gallant, MD, Vice-Chair, Infectious Diseases, HIVMA and Professor of Medicine at Johns Hopkins University School of Medicine, Baltimore, MD. Hosted by Fred Schaich, IFARA, Portland, OR.

Both Michael and Joel reiterate why sustaining federal funding in a time of "treatment as prevention" is so critical. They present astounding data about the small percentage of people on effective treatment today along with the science-based benefit to testing and linkage to care, geographic incidence, and healthcare reform’s effect on the patient and on providers.

CROI 2012: John Coffin - Basic Science

John M. Coffin, PhD, Professor of Molecular biology and Microbiology Genetics, Microbiology, Tufts, Sackler, School of Graduate Biomedical Sciences, Boston, MA.

As chair of this year’s CROI, Dr. Coffin reviews some of the more important basic science that was presented this year, which includes: evolutionary aspects and how they affect replication, valuable genomic factor relationship to HIV pathogenesis, viral mechanisms, disruptive agents and the need for agents to specifically turn on latent virus. He is always interesting to speak with about the amazing backstory to science in HIV research.

CROI 2012: Luis E. Soto Ramirez

Luis E. Soto Ramirez, MD, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, DF, Mexico, Interview in Spanish by Rob Camp.

CROI 2012: Marcus Conant

Marcus Conant, MD, Chairman/Founder – Marcus Conant Foundation, and physician in private practice.

In this interview, Dr. Conant offers the story of his being one of the first HIV/AIDS physicians in the US, due to his specialty being dermatology and the initial skin manifestation of Karposi's Sarcoma, as one of the first symptoms for HIV/AIDS. He makes a strong case for full funding to "start stopping this disease" through treatment as prevention, and for the patient and provider community to become activist in demanding more from industry, regulators and government to make this happen.

CROI 2012: Dennis Burton

Dennis Burton, PhD, Professor, Burton Laboratory, The Scripps Research Institute, La Jolla, CA.

Dr. Burton is one of the most respected, invested researchers in the field of HIV vaccine research. In this interview, he offers his sense of where we are today in this work around broadly neutralizing antibodies and some sense of where we are going in this very complicated area of research.

CROI 2012: Fair Pricing Coalition

"Fair Pricing Coalition" Panel hosted by Lynda Dee, MD, AIDS Action Baltimore, with participants Murray Penner, Deputy Director, NASTAD, Washington, DC; Jeff Berry, editor- Positively Aware, Chicago; and David Evans, Director of Research Advocacy, Project Inform, San Francisco, CA; all of whom are members of the Fair Pricing Coalition.

The panel discusses advocacy for: reasonable initial price setting, reasonable price increases, ADAP drug rebates, patient assistance programs, price freezes, co-pay assistance programs and federally funded Part D programs.

CROI 2012: Treatment as Prevention Montage

Comments from a number of people, about the use of antiretrovirals in prevention of transmission of HIV.

CROI 2012: 19th CROI Introduction

If you are interested in hosting a viewing site for the Treatment Update program on Thursday, March 8, 2012, please download and return the Host Agreement Form.